Caplight Directory>Companies>Asahi Pharma Co., Ltd.-preview>Asahipharma


Asahi Pharma Co., Ltd.

Asahi Pharma Co., Ltd.

Private
TsukubaHealthcare & Life Scienceshttps://www.asahipharma.com/

Last Round

VC Round

Oct 23, 2025

Company Overview

Asahi Pharma Co., Ltd. is a biotechnology company that conducts research and development of novel small-molecule therapeutics for xerostomia (dry mouth).

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

small molecule drugsdrug discoveryxerostomiadry mouthbiotechnologybiopharmabiotech R&Dpharma partneringdrug licensingpre-commercial biotechdrug pipelinesalivary secretion

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Asahi Pharma Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Asahi Pharma Co., Ltd. Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundOct 23, 2025
View all Funding Rounds

Asahi Pharma Co., Ltd. Investors

Notable investors and investment history

InvestorRounds
Tohoku University Venture PartnersVC Round
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 23, 2025

    $660K round led by Tohoku University Venture Partners.

View all signals

Asahi Pharma Co., Ltd. Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Asahi Pharma Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Asahi Pharma Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersTsukuba
Year Founded2022
Last FundingOct 23, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.